Procter & Gamble Health Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Jun'26

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Jun 2026 is 7.37% vs 19.33% in Jun 2025

Standalone Net Profit

YoY Growth in quarter ended Jun 2026 is 45.29% vs 294.40% in Jun 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 10.25% vs 87.23% in Jun 2025

Interest

YoY Growth in quarter ended Jun 2026 is 16.67% vs -40.00% in Jun 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of P & G Health Ltd With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

363.71

235.70

128.01

54.31%

Other Operating Income

0.00

Total Operating income

363.71

235.70

128.01

54.31%

Raw Material Cost

80.31

47.50

32.81

69.07%

Purchase of Finished goods

24.56

16.00

8.56

53.50%

(Increase) / Decrease In Stocks

-8.65

-7.20

-1.45

-20.14%

Employee Cost

60.39

31.30

29.09

92.94%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

107.50

58.80

48.70

82.82%

Total Expenditure (Excl Depreciation)

264.11

146.40

117.71

80.40%

Operating Profit (PBDIT) excl Other Income

99.60

89.30

10.30

11.53%

Other Income

3.88

6.30

-2.42

-38.41%

Operating Profit (PBDIT)

103.48

95.60

7.88

8.24%

Interest

0.14

0.40

-0.26

-65.00%

Exceptional Items

31.80

0.00

31.80

Gross Profit (PBDT)

135.14

95.20

39.94

41.95%

Depreciation

6.02

3.30

2.72

82.42%

Profit Before Tax

129.12

91.90

37.22

40.50%

Tax

32.97

23.10

9.87

42.73%

Provisions and contingencies

0.00

Profit After Tax

96.15

68.80

27.35

39.75%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

96.15

68.80

27.35

39.75%

Equity Capital

16.60

23.00

-6.40

-27.83%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

57.92

29.91

28.01

93.65%

Diluted Earnings per share

57.92

29.87

28.05

93.91%

Operating Profit Margin (Excl OI)

27.38%

37.89%

0.00

-10.51%

Gross Profit Margin

37.16%

40.39%

0.00

-3.23%

PAT Margin

26.44%

29.19%

0.00

-2.75%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 363.71 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -1.82% vs -0.91% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 7.37% vs 19.33% in Jun 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 96.15 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 1.64% vs 21.92% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 45.29% vs 294.40% in Jun 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 99.60 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -26.54% vs 22.75% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 10.25% vs 87.23% in Jun 2025

Quarterly - Interest

Interest 0.14 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -33.33% vs 110.00% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 16.67% vs -40.00% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 27.38%

in Jun 2026

Figures in %

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025